ArticleJournal of thoracic disease2026
Global trends and hotspots in oxidative stress and esophageal cancer research: a comprehensive bibliometric and visualized analysis based on the Web of Science Core Collection (1998-2026).
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oxidative stress plays a pivotal role in esophageal cancer (EC) pathogenesis, with emerging redox biomarkers-such as the systemic oxidative stress index (SOSI)-demonstrating significant prognostic value in advanced management, including neoadjuvant immunochemotherapy. However, a comprehensive audit of the global research structure and thematic evolution at this intersection remains absent. This study aims to map the intellectual landscapes and paradigm shifts in this evolving field. Methods: Literature published between January 1, 1998 and May 13, 2026 was retrieved from the Web of Science Core Collection (WoSCC) using a comprehensive topic search strategy: TS=("esophageal neoplasm" OR "esophageal cancer") AND TS=("oxidative stress" OR "reactive oxygen species" OR "lipid peroxidation"). Only original English research articles were included. Bibliometric parameters and network visualizations were thoroughly evaluated using Microsoft Excel, VOSviewer, CiteSpace, and R software. Results: A final cohort of 355 original articles exhibited a steady annual growth rate of 7.94%, with China dominating the publication volume (56.9%) and the USA leading international collaborations. The thematic evolution over the past 28 years revealed a profound paradigm shift divided into three distinct stages: transitioning from early toxicological profiling and environmental carcinogen-induced oxidative injuries (e.g., mycotoxins and lipid peroxidation) to histological characterizations, and ultimately culminating in contemporary frontiers centered on novel cell death pathways (ferroptosis, pyroptosis, autophagy) and tumor microenvironment (TME) homeostasis. Conclusions: This study delineates the shifting paradigms of redox oncology in EC, highlighting a critical transition toward cell death mechanisms and targeted therapeutic validation. Although limited by its restriction to a single database (WoSCC) and English-only publications, these findings provide essential "evidence-based navigation" to optimize resource allocation and foster cross-regional collaborations for precision therapeutic strategies in high-burden regions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.